fbpx Skip to main content

BioCommunique Article

Bringing you the latest financial and strategic news from top leaders in life science.

BD Launches 15-Minute Coronavirus Antigen Test, Takeda & Twist Bioscience Forge Biologics Partnership, Illumina Launches TruSight Software Suite

  • 2020-07-08T19:00:00.000+0000
  • California
  • Author: Lauren Panetta

7/9/20 – Assembly Biosciences

Assembly Biosciences Announces FDA Fast Track Designation Granted to ABI-H2158 for the Treatment of Chronic Hepatitis B Virus Infection

7/9/20 – Xconomy

VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs

7/9/20 – BioSpace

IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Binimetinib, a MEK Inhibitor

7/9/20 – ChemoCentryx

ChemoCentryx Submits New Drug Application to the U.S. FDA for Avacopan in ANCA-Associated Vasculitis

7/9/20 – FierceBiotech

Sanofi pays $150M upfront, $2B in biobucks for Kymera I&I deal

7/8/20 – BioSpace

Takeda Taps Twist Bioscience to Boost Biologics Discovery Capabilitie

7/8/20 – Illumina

Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases

7/8/20 – FierceBiotech

Merck teams up with cancer startup Foghorn in $425M deal

7/8/20 – BlueNalu

BlueNalu Signs MOU with Pulmuone, Announces Partnership Bringing Cell-Based Seafood to South Korea

7/8/20 – Thermo Fisher Scientific

Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Chugai Pharmaceutical

7/8/20 – Tandem Diabetes

JDRF and Tandem Diabetes Care Partner to Help Educate and Support the T1D Community

7/7/20 – FierceBiotech

BD launches 15-minute coronavirus antigen test

7/7/20 – Salk

Salk Scientists Discover Genetic "Dial" to Turn Immune Function Up and Down to Target Cancer, Autoimmune Disease

7/7/20 – BioSpace

GSK, Medicago Forge Agreement to Develop Novel Adjuvanted COVID-19 Vaccine

7/7/20 – FierceBiotech

Novartis marries Propeller's inhaler tech with new asthma med

7/6/20 – Xconomy

Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases

7/6/20 – The San Diego Union-Tribune

Poseida Therapeutics sets terms for upcoming IPO, aims to raise $150M for cancer treatments

7/6/20 – FierceBiotech

Boehringer creates hub to connect with Chinese R&D groups

7/6/20 – Endpoints News

Pfizer re-ups on Mission Therapeutics collaboration, leading a $15M round and grabbing first dibs on DUBs

7/6/20 – FierceBiotech

Biogen joins Harvard in gene therapy pact to fight eye disease

7/1/20 – Xconomy

Bolt Bio Adds $93.5M to Move Ahead Immune-Stimulating Cancer Drugs

6/30/20 – Xconomy

Ultragenyx Pharma Wins FDA’s First Drug Nod for Rare Metabolic Disorder

6/29/20 – Xconomy

Roche Gets FDA OK for Injectable Version of Breast Cancer Drug